In gastric cancer patients (39–41) and uterine cervical or corpus cancer patients (42), the efficacy of rikkunshito for ghrelin concentration and gastrointestinal dysfunction, including feeding, was evaluated. This evidence concerns the gene GHRL and gastric cancer.